John Franzone

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial”.

Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial

The Lancet Infectious Diseases(2021)10.1016/s1473-3099(21)00751-9

N/A

6.2DataRank · unranked

194 citations

Uriel Sandkovsky, Cavan S. Reilly, David M. Vock, Robert L. Gottlieb, Michael Mack +95 more

Microbial Cell-Free DNA Identifies the Causative Pathogen in Infective Endocarditis and Remains Detectable Longer Than Conventional Blood Culture in Patients with Prior Antibiotic Therapy

Clinical Infectious Diseases(2022)10.1093/cid/ciac426

N/A

0DataRank · unranked

82 citations

Nicholas Degner, Erick R. Scott, Felicia Ruffin, John Franzone, Batu K. Sharma‐Kuinkel +12 more

Current treatment options for pneumonia caused by carbapenem-resistant Acinetobacter baumannii

UNC Libraries(2025)10.17615/2ysx-7c73

N/A

0DataRank · unranked

0 citations

Natalie Mackow, John Franzone, David van Duin